Veeva Systems

Seeing our customers at Veeva Commercial Summit embrace the shift toward an agentic future was incredibly exciting. But to unlock that potential, the foundation must be right. The defining theme from our conversations was clear: we cannot build tomorrow’s agents on yesterday’s fragmented, slow and incomplete data. As therapies become more complex, legacy data becomes a critical bottleneck, directly limiting the industry's ability to reach patients with the therapies they need. Thanks to [MM+M - Medical Marketing and Media](https://www.linkedin.com/company/medical-marketing-media-mmm) for publishing a great recap highlighting how a modern data foundation is the ultimate prerequisite to scaling AI and accelerating patient discovery. Read it here: <https://lnkd.in/eNyKMcjS> Jump to the sections titled “Accelerating discovery in rare disease” and “Complex therapies driving need for more complete data” to learn how companies like [Zevra Therapeutics](https://www.linkedin.com/company/zevratherapeutics) and [Moderna](https://www.linkedin.com/company/modernatx) are already shifting their data strategies to prepare for the agentic era. I’d love to hear your thoughts. Are you seeing the same in your business? [#lifesciences](https://www.linkedin.com/feed/hashtag/lifesciences) [#DataCloud](https://www.linkedin.com/feed/hashtag/datacloud) [#AI](https://www.linkedin.com/feed/hashtag/ai) [#HealthcareData](https://www.linkedin.com/feed/hashtag/healthcaredata)